[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Prostate Cancer Drugs Market Report 2017

October 2017 | 127 pages | ID: A5E33A1839FPEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Prostate Cancer Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Prostate Cancer Drugs for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Prostate Cancer Drugs market competition by top manufacturers/players, with Prostate Cancer Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • AbbVie
  • Astellas Pharma
  • Astra Zeneca
  • Johnson & Johnson
  • Sanofi
  • GlaxoSmithKline
  • Merck Group
  • Novartis
  • Amgen
  • Bayer HealthCare
  • Ferring Pharmaceutical
  • Janssen Pharmaceuticals
  • Endo Pharmaceuticals
  • BMS
  • Takeda Pharmaceuticals
  • Northwest Biotherapeutics
  • Teva Pharmaceutical
  • Boehringer Ingelheim
  • Foresee Pharmaceuticals
  • Tokai Pharmaceuticals
  • Spectrum Pharmaceuticals
On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
  • Hormonal Therapy
  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Prostate Cancer Drugs for each application, includin
  • Clinics
  • Hospitals
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Prostate Cancer Drugs Market Report 2017

1 PROSTATE CANCER DRUGS OVERVIEW

1.1 Product Overview and Scope of Prostate Cancer Drugs
1.2 Classification of Prostate Cancer Drugs by Product Category
  1.2.1 Asia-Pacific Prostate Cancer Drugs Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Prostate Cancer Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Hormonal Therapy
  1.2.4 Chemotherapy
  1.2.5 Immunotherapy
  1.2.6 Targeted Therapy
1.3 Asia-Pacific Prostate Cancer Drugs Market by Application/End Users
  1.3.1 Asia-Pacific Prostate Cancer Drugs Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Clinics
  1.3.3 Hospitals
  1.3.4 Other
1.4 Asia-Pacific Prostate Cancer Drugs Market by Region
  1.4.1 Asia-Pacific Prostate Cancer Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Prostate Cancer Drugs (2012-2022)
  1.5.1 Asia-Pacific Prostate Cancer Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Prostate Cancer Drugs Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC PROSTATE CANCER DRUGS COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Prostate Cancer Drugs Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Prostate Cancer Drugs Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Prostate Cancer Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Prostate Cancer Drugs (Volume and Value) by Type
  2.2.1 Asia-Pacific Prostate Cancer Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Prostate Cancer Drugs Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Prostate Cancer Drugs (Volume) by Application
2.4 Asia-Pacific Prostate Cancer Drugs (Volume and Value) by Region
  2.4.1 Asia-Pacific Prostate Cancer Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Prostate Cancer Drugs Revenue and Market Share by Region (2012-2017)

3 CHINA PROSTATE CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 China Prostate Cancer Drugs Sales and Value (2012-2017)
  3.1.1 China Prostate Cancer Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Prostate Cancer Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 China Prostate Cancer Drugs Sales Price Trend (2012-2017)
3.2 China Prostate Cancer Drugs Sales Volume and Market Share by Type
3.3 China Prostate Cancer Drugs Sales Volume and Market Share by Application

4 JAPAN PROSTATE CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Prostate Cancer Drugs Sales and Value (2012-2017)
  4.1.1 Japan Prostate Cancer Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Prostate Cancer Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Prostate Cancer Drugs Sales Price Trend (2012-2017)
4.2 Japan Prostate Cancer Drugs Sales Volume and Market Share by Type
4.3 Japan Prostate Cancer Drugs Sales Volume and Market Share by Application

5 SOUTH KOREA PROSTATE CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Prostate Cancer Drugs Sales and Value (2012-2017)
  5.1.1 South Korea Prostate Cancer Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Prostate Cancer Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Prostate Cancer Drugs Sales Price Trend (2012-2017)
5.2 South Korea Prostate Cancer Drugs Sales Volume and Market Share by Type
5.3 South Korea Prostate Cancer Drugs Sales Volume and Market Share by Application

6 TAIWAN PROSTATE CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Prostate Cancer Drugs Sales and Value (2012-2017)
  6.1.1 Taiwan Prostate Cancer Drugs Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Prostate Cancer Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Prostate Cancer Drugs Sales Price Trend (2012-2017)
6.2 Taiwan Prostate Cancer Drugs Sales Volume and Market Share by Type
6.3 Taiwan Prostate Cancer Drugs Sales Volume and Market Share by Application

7 INDIA PROSTATE CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 India Prostate Cancer Drugs Sales and Value (2012-2017)
  7.1.1 India Prostate Cancer Drugs Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Prostate Cancer Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 India Prostate Cancer Drugs Sales Price Trend (2012-2017)
7.2 India Prostate Cancer Drugs Sales Volume and Market Share by Type
7.3 India Prostate Cancer Drugs Sales Volume and Market Share by Application

8 SOUTHEAST ASIA PROSTATE CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Prostate Cancer Drugs Sales and Value (2012-2017)
  8.1.1 Southeast Asia Prostate Cancer Drugs Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Prostate Cancer Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Prostate Cancer Drugs Sales Price Trend (2012-2017)
8.2 Southeast Asia Prostate Cancer Drugs Sales Volume and Market Share by Type
8.3 Southeast Asia Prostate Cancer Drugs Sales Volume and Market Share by Application

9 AUSTRALIA PROSTATE CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Prostate Cancer Drugs Sales and Value (2012-2017)
  9.1.1 Australia Prostate Cancer Drugs Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Prostate Cancer Drugs Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Prostate Cancer Drugs Sales Price Trend (2012-2017)
9.2 Australia Prostate Cancer Drugs Sales Volume and Market Share by Type
9.3 Australia Prostate Cancer Drugs Sales Volume and Market Share by Application

10 ASIA-PACIFIC PROSTATE CANCER DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 AbbVie
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Prostate Cancer Drugs Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 AbbVie Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Astellas Pharma
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Prostate Cancer Drugs Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Astra Zeneca
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Prostate Cancer Drugs Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Johnson & Johnson
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Prostate Cancer Drugs Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Johnson & Johnson Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Sanofi
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Prostate Cancer Drugs Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Sanofi Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 GlaxoSmithKline
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Prostate Cancer Drugs Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 GlaxoSmithKline Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Merck Group
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Prostate Cancer Drugs Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Merck Group Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Novartis
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Prostate Cancer Drugs Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Novartis Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Amgen
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Prostate Cancer Drugs Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Amgen Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Bayer HealthCare
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Prostate Cancer Drugs Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Bayer HealthCare Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 Ferring Pharmaceutical
10.12 Janssen Pharmaceuticals
10.13 Endo Pharmaceuticals
10.14 BMS
10.15 Takeda Pharmaceuticals
10.16 Northwest Biotherapeutics
10.17 Teva Pharmaceutical
10.18 Boehringer Ingelheim
10.19 Foresee Pharmaceuticals
10.20 Tokai Pharmaceuticals
10.21 Spectrum Pharmaceuticals

11 PROSTATE CANCER DRUGS MANUFACTURING COST ANALYSIS

11.1 Prostate Cancer Drugs Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Prostate Cancer Drugs

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Prostate Cancer Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC PROSTATE CANCER DRUGS MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Prostate Cancer Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Prostate Cancer Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Prostate Cancer Drugs Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Prostate Cancer Drugs Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Prostate Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Prostate Cancer Drugs Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Prostate Cancer Drugs Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Prostate Cancer Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Prostate Cancer Drugs Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Prostate Cancer Drugs Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Prostate Cancer Drugs Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Prostate Cancer Drugs Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Prostate Cancer Drugs
Figure Asia-Pacific Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2012-2022)
Figure Asia-Pacific Prostate Cancer Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Hormonal Therapy Product Picture
Figure Chemotherapy Product Picture
Figure Immunotherapy Product Picture
Figure Targeted Therapy Product Picture
Figure Asia-Pacific Prostate Cancer Drugs Sales (K Pcs) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Prostate Cancer Drugs by Application in 2016
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Other Examples
Table Key Downstream Customer in Other
Figure Asia-Pacific Prostate Cancer Drugs Market Size (Million USD) by Region (2012-2022)
Figure China Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Prostate Cancer Drugs Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Asia-Pacific Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Prostate Cancer Drugs Market Major Players Product Sales Volume (K Pcs)(2012-2017)
Table Asia-Pacific Prostate Cancer Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Prostate Cancer Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Prostate Cancer Drugs Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Prostate Cancer Drugs Sales Share by Players/Suppliers
Figure Asia-Pacific Prostate Cancer Drugs Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Prostate Cancer Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Prostate Cancer Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Prostate Cancer Drugs Revenue Share by Players
Figure 2017 Asia-Pacific Prostate Cancer Drugs Revenue Share by Players
Table Asia-Pacific Prostate Cancer Drugs Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Prostate Cancer Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Prostate Cancer Drugs by Type (2012-2017)
Figure Asia-Pacific Prostate Cancer Drugs Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Prostate Cancer Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Prostate Cancer Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Prostate Cancer Drugs by Type (2012-2017)
Figure Asia-Pacific Prostate Cancer Drugs Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Prostate Cancer Drugs Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Asia-Pacific Prostate Cancer Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Prostate Cancer Drugs by Region (2012-2017)
Figure Asia-Pacific Prostate Cancer Drugs Sales Market Share by Region in 2016
Table Asia-Pacific Prostate Cancer Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Prostate Cancer Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Prostate Cancer Drugs by Region (2012-2017)
Figure Asia-Pacific Prostate Cancer Drugs Revenue Market Share by Region in 2016
Table Asia-Pacific Prostate Cancer Drugs Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Asia-Pacific Prostate Cancer Drugs Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Prostate Cancer Drugs Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Prostate Cancer Drugs Sales Market Share by Application (2012-2017)
Figure China Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table China Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table China Prostate Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Prostate Cancer Drugs Sales Volume Market Share by Type in 2016
Table China Prostate Cancer Drugs Sales Volume (K Pcs) by Applications (2012-2017)
Table China Prostate Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Prostate Cancer Drugs Sales Volume Market Share by Application in 2016
Figure Japan Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Prostate Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Prostate Cancer Drugs Sales Volume Market Share by Type in 2016
Table Japan Prostate Cancer Drugs Sales Volume (K Pcs) by Applications (2012-2017)
Table Japan Prostate Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Prostate Cancer Drugs Sales Volume Market Share by Application in 2016
Figure South Korea Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure South Korea Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table South Korea Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table South Korea Prostate Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure South Korea Prostate Cancer Drugs Sales Volume Market Share by Type in 2016
Table South Korea Prostate Cancer Drugs Sales Volume (K Pcs) by Applications (2012-2017)
Table South Korea Prostate Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure South Korea Prostate Cancer Drugs Sales Volume Market Share by Application in 2016
Figure Taiwan Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Taiwan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Taiwan Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Taiwan Prostate Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Prostate Cancer Drugs Sales Volume Market Share by Type in 2016
Table Taiwan Prostate Cancer Drugs Sales Volume (K Pcs) by Applications (2012-2017)
Table Taiwan Prostate Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Prostate Cancer Drugs Sales Volume Market Share by Application in 2016
Figure India Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table India Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table India Prostate Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Prostate Cancer Drugs Sales Volume Market Share by Type in 2016
Table India Prostate Cancer Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table India Prostate Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Prostate Cancer Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Prostate Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Prostate Cancer Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Prostate Cancer Drugs Sales Volume (K Pcs) by Applications (2012-2017)
Table Southeast Asia Prostate Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Prostate Cancer Drugs Sales Volume Market Share by Application in 2016
Figure Australia Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Australia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Australia Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Australia Prostate Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure Australia Prostate Cancer Drugs Sales Volume Market Share by Type in 2016
Table Australia Prostate Cancer Drugs Sales Volume (K Pcs) by Applications (2012-2017)
Table Australia Prostate Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure Australia Prostate Cancer Drugs Sales Volume Market Share by Application in 2016
Table AbbVie Prostate Cancer Drugs Basic Information List
Table AbbVie Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AbbVie Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure AbbVie Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure AbbVie Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Astellas Pharma Prostate Cancer Drugs Basic Information List
Table Astellas Pharma Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Astellas Pharma Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Astellas Pharma Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Astellas Pharma Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Astra Zeneca Prostate Cancer Drugs Basic Information List
Table Astra Zeneca Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Astra Zeneca Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Astra Zeneca Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Astra Zeneca Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Johnson & Johnson Prostate Cancer Drugs Basic Information List
Table Johnson & Johnson Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Johnson & Johnson Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Johnson & Johnson Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Sanofi Prostate Cancer Drugs Basic Information List
Table Sanofi Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Sanofi Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Sanofi Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table GlaxoSmithKline Prostate Cancer Drugs Basic Information List
Table GlaxoSmithKline Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure GlaxoSmithKline Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Merck Group Prostate Cancer Drugs Basic Information List
Table Merck Group Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Group Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Merck Group Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Merck Group Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Novartis Prostate Cancer Drugs Basic Information List
Table Novartis Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Novartis Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Novartis Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Amgen Prostate Cancer Drugs Basic Information List
Table Amgen Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amgen Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Amgen Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Amgen Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Bayer HealthCare Prostate Cancer Drugs Basic Information List
Table Bayer HealthCare Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer HealthCare Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bayer HealthCare Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Bayer HealthCare Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Ferring Pharmaceutical Prostate Cancer Drugs Basic Information List
Table Janssen Pharmaceuticals Prostate Cancer Drugs Basic Information List
Table Endo Pharmaceuticals Prostate Cancer Drugs Basic Information List
Table BMS Prostate Cancer Drugs Basic Information List
Table Takeda Pharmaceuticals Prostate Cancer Drugs Basic Information List
Table Northwest Biotherapeutics Prostate Cancer Drugs Basic Information List
Table Teva Pharmaceutical Prostate Cancer Drugs Basic Information List
Table Boehringer Ingelheim Prostate Cancer Drugs Basic Information List
Table Foresee Pharmaceuticals Prostate Cancer Drugs Basic Information List
Table Tokai Pharmaceuticals Prostate Cancer Drugs Basic Information List
Table Spectrum Pharmaceuticals Prostate Cancer Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Pcs) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostate Cancer Drugs
Figure Manufacturing Process Analysis of Prostate Cancer Drugs
Figure Prostate Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2016
Table Major Buyers of Prostate Cancer Drugs
Table Distributors/Traders List
Figure Asia-Pacific Prostate Cancer Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Prostate Cancer Drugs Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Asia-Pacific Prostate Cancer Drugs Sales Volume (K Pcs) Forecast by Region (2017-2022)
Figure Asia-Pacific Prostate Cancer Drugs Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Prostate Cancer Drugs Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Prostate Cancer Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Prostate Cancer Drugs Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Prostate Cancer Drugs Revenue Market Share Forecast by Region in 2022
Figure China Prostate Cancer Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Prostate Cancer Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Prostate Cancer Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure South Korea Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Prostate Cancer Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Taiwan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Prostate Cancer Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Prostate Cancer Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Prostate Cancer Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Australia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Prostate Cancer Drugs Sales (K Pcs) Forecast by Type (2017-2022)
Figure Asia-Pacific Prostate Cancer Drugs Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Prostate Cancer Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Prostate Cancer Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Prostate Cancer Drugs Price (USD/Pcs) Forecast by Type (2017-2022)
Table Asia-Pacific Prostate Cancer Drugs Sales (K Pcs) Forecast by Application (2017-2022)
Figure Asia-Pacific Prostate Cancer Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories